Regular Article
Methimazole Toxicity in Rodents: Covalent Binding in the Olfactory Mucosa and Detection of Glial Fibrillary Acidic Protein in the Olfactory Bulb

https://doi.org/10.1006/taap.1998.8590Get rights and content

Abstract

Methimazole is an antithyroid drug reported to affect the sense of smell and taste in humans. The aim of the present study was to examine the distribution and effects of methimazole on the olfactory system in rodents. Autoradiography showed a selective covalent binding of3H-labeled methimazole in the Bowman's glands in the olfactory mucosa, bronchial epithelium in the lungs, and centrilobular parts of the liver following an iv injection in mice. Histopathology showed an extensive lesion in the olfactory mucosa that was efficiently repaired 3 months after two consecutive ip doses of methimazole. The effect of methimazole on various brain regions was studied by determining levels and location of glial fibrillary acidic protein (GFAP). The results showed a threefold increase of GFAP in the olfactory bulb 2 weeks after treatment with methimazole whereas no change was observed 4 days after treatment. Pretreatment of mice with thyroxine did not protect against the methimazole-induced toxicity in the olfactory mucosa and bulb. In contrast, pretreatment with the cytochrome P450 inhibitor metyrapone completely prevented the covalent binding and toxicity of methimazole in the olfactory mucosa and bulb. The present results suggest that the methimazole-induced toxicity in the olfactory mucosa is mediated by a cytochrome P450-dependent metabolic activation of the compound into reactive metabolites that are bound to various tissues including the olfactory mucosa. The increase of GFAP in the olfactory bulb of methimazole-treated mice is suggested to be a secondary phenomenon due to the primary damage in the olfactory mucosa.

References (46)

  • A. Mackay-Sim et al.

    Hypothyroidism disrupts neural development in the olfactory epithelium of adult mice

    Brain Res.

    (1987)
  • J.P. O'Callaghan

    Quantification of glial fibrillary acidic protein: Comparision of slot-immunobinding assays with a novel sandwich ELISA

    Neurotoxicol. Teratol.

    (1991)
  • J.P. O'Callaghan et al.

    Quantitative aspects of drug and toxicant-induced astrogliosis

    Neurochem. Int.

    (1995)
  • M.A. Paternostro et al.

    Developmental plasticity of the rat olfactory receptor sheet as shown by complete recovery of surface area and cell number from extensive early hypothyroid growth retardation

    Brain Res. Dev. Brain Res.

    (1993)
  • M.A. Paternostro et al.

    Quantitative [3

    Brain Res. Dev. Brain Res.

    (1994)
  • L.L. Poulsen et al.

    S

    Biochem. Pharmacol.

    (1974)
  • J.R. Thornton-Manning et al.

    Metabolic capacity of nasal tissue interspecies comparisons of xenobiotic-metabolizing enzymes

    Mutat. Res.

    (1997)
  • J.T. Young

    Histopathological examination of the rat nasal cavity

    Fundam. Appl. Toxicol.

    (1981)
  • D.R. Adams et al.

    Distribution of cytochrome P-450 monoxygenase enzymes in the nasal mucosa of hamster and rat

    Am. J. Anat.

    (1991)
  • J.J. Anders et al.

    Transection of the rat olfactory nerve increases glial fibrillary acidic protein immunoreactivity from the olfactory bulb to the piriform cortex

    Glia

    (1990)
  • M.S. Bailey et al.

    Astrocyte subtypes in the rat olfactory bulb: Morphological heterogeneity and differential laminar distribution

    J. Comp. Neurol.

    (1993)
  • E.B. Brittebo

    Metabolism-dependent toxicity of methimazole in the olfactory nasal mucosa

    Pharmacol. Toxicol.

    (1995)
  • Cited by (0)

    E. MeisamiM. A. B. Brazier

    View full text